幼年起病与成人起病亨廷顿病临床谱比较:全国队列与Enroll-HD观察性研究
该研究比较了儿童起病JHD、青少年起病JHD与成人起病HD的临床特征出现比例及严重程度。合并数据集包括46例cJHD、243例aJHD和9504例AHD。cJHD神经认知症状比例显著高于aJHD和AHD;aJHD精神症状、攻击行为和精神病性症状比例显著高于AHD;JHD亚型在构音障碍、帕金森综合征和肌张力障碍的UHDRS-TMS中位数高于AHD,舞蹈症中位数低于AHD。
要点
- cJHD起病时神经认知症状比例显著高于aJHD和AHD。
- aJHD精神症状、攻击行为和精神病性症状比例显著高于AHD。
- 起病6-10年后JHD亚型构音障碍、帕金森综合征和肌张力障碍中位数高于AHD,舞蹈症低于AHD。
核心结论
- JHD亚型与AHD相比具有不同的临床模式。
- 未来研究需要按起病年龄定义HD亚型进行分层。
研究设计与样本
- 使用全国幼年起病HD患者队列和国际Enroll-HD注册研究(NCT01574053)的合并数据。
- 比较儿童起病JHD(起病年龄0-10岁)、青少年起病JHD(起病年龄11-20岁)和成人起病HD(起病年龄21-65岁)在起病时临床特征比例及精神症状特征。
- 对Enroll-HD数据集中起病后6-10年的UHDRS-TMS项目采用Kruskal-Wallis检验比较运动症状严重程度。
主要发现
- 合并数据集包括46例cJHD(平均起病年龄6.70岁,女性45%)、243例aJHD(平均起病年龄16.70岁,女性46%)和9504例AHD(平均起病年龄44.70岁,女性51%)。
- 起病时神经认知症状发生在47.50%的cJHD患者(n=46;95%CI 31.80%-63.70%),显著高于aJHD患者的24.88%(n=209;95%CI 19.30%-31.40%)和AHD患者的15.02%(n=8177;95%CI 14.30%-15.80%)。
- 精神症状发生在47.12%的aJHD患者(95%CI 40.20%-54.10%),显著高于AHD患者的31.04%(95%CI 30.10%-32.00%)。
- 整个疾病过程中,攻击行为发生在73.91%的cJHD患者(n=46;95%CI 58.60%-85.20%)和55.88%的aJHD患者(n=238;95%CI 49.30%-62.30%),显著高于AHD患者的40.65%(n=9501;95%CI 39.70%-41.70%)。
- 精神病性症状发生在23.53%的aJHD患者(95%CI 18.40%-29.50%),显著高于AHD患者的12.77%(95%CI 12.10%-13.50%)。
关键数值与推荐
- 构音障碍:AHD(n=4163)中位数1.00,IQR 0.70;cJHD(n=12)中位数2.20,IQR 2.00,p=0.039;aJHD(n=93)中位数1.00,IQR 1.00,p=0.031。
- 帕金森综合征:AHD(n=4158)中位数6.00,IQR 4.70;cJHD(n=12)中位数11.00,IQR 9.40,p=0.008;aJHD(n=93)中位数8.50,IQR 6.80,p<0.001。
- 肌张力障碍:AHD(n=4161)中位数2.00,IQR 5.20;cJHD(n=12)中位数6.50,IQR 8.20,p=0.141;aJHD(n=93)中位数4.00,IQR 7.20,p=0.015。
- 舞蹈症:AHD(n=4163)中位数9.20,IQR 7.00;cJHD(n=12)中位数5.00,IQR 4.20,p<0.001;aJHD(n=93)中位数6.30,IQR 9.50,p<0.001。
临床怎么用
- 临床中应关注不同起病年龄HD亚型的特征性表现:cJHD更多神经认知症状,aJHD更多精神症状和精神病性症状。
- JHD亚型运动症状以构音障碍、帕金森综合征和肌张力障碍更突出,舞蹈症相对较轻。
- 未来研究和临床分层需考虑按起病年龄定义的HD亚型。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Differences in clinical characteristics between juvenile-onset Huntington disease (JHD) and adult-onset HD (AHD) are hypothesized but not directly compared. This study compares clinical characteristics occurrence and severity across age-at-onset (AO) subtypes. METHODS: Using the national juvenile-onset HD patient cohort and the international Enroll-HD registry (NCT01574053), we compared childhood-onset JHD (cJHD; AO 0-10), adolescent-onset JHD (aJHD; AO 11-20), and adult-onset HD (AHD; AO 21-65) on proportions of clinical characteristics at onset and psychiatric characteristics in pooled datasets. Kruskal-Wallis test was applied to UHDRS-Total Motor Score (UHDRS-TMS) items of the Enroll-HD dataset to compare the severity of motor disease characteristics 6-10 years after onset. RESULTS: The combined datasets provided data from 46 patients with cJHD (mean AO 6.70, 45% female), 243 patients with aJHD (mean AO 16.70, 46% female), and 9,504 patients with AHD (mean AO 44.70, 51% female). At onset, neurocognitive symptoms occurred in 47.50% of patients with cJHD (n = 46; 95% CI 31.80%-63.70%), significantly more often compared with 24.88% of patients with aJHD (n = 209; 19.30%-31.40%) and 15.02% of those with AHD (n = 8,177; 14.30%-15.80%). Psychiatric symptoms occurred in 47.12% of patients with aJHD (95% CI 40.20%-54.10%), significantly more compared with 31.04% of patients with AHD (30.10%-32.00%). Throughout the disease, aggressive behavior occurred in 73.91% of patients with cJHD (n = 46; 95% CI 58.60%-85.20%) and 55.88% of those with aJHD (n = 238; 49.30%-62.30%), significantly more compared with 40.65% of patients with AHD (n = 9,501; 39.70%-41.70%). Psychosis occurred in 23.53% of patients with aJHD (95% CI 18.40%-29.50%), significantly more compared with 12.77% of those with AHD (12.10%-13.50%). The Kruskal-Wallis test revealed significantly higher median UHDRS-TMS scores in one or both JHD subtypes compared with AHD for dysarthria (AHD: n = 4,163, median 1.00, interquartile range (IQR) 0.70; cJHD: n = 12, 2.20, 2.00, p = 0.039; aJHD: n = 93, 1.00, 1.00, p = 0.031), parkinsonism (AHD: n = 4,158, median 6.00, IQR 4.70; cJHD: n = 12, 11.00, 9.40, p = 0.008; aJHD: n = 93, 8.50, 6.80, p < 0.001), and dystonia (AHD: n = 4,161, median 2.00, IQR 5.20; cJHD: n = 12, 6.50, 8.20, p = 0.141; aJHD: n = 93, 4.00, 7.20, p = 0.015) and significantly lower median scores for chorea (AHD: n = 4,163, median 9.20, IQR 7.00; cJHD: n = 12, 5.00, 4.20, p = <0.001; aJHD: n = 93, 6.30, 9.50, p < 0.001). DISCUSSION: This study highlights distinct clinical patterns in JHD subtypes compared with AHD. Stratification by age at onset-defined HD subtypes is needed in future studies.
引用
- Bakels HS, van der Zwaan KF, Van Zwet E, et al. Comparison of the Clinical Spectrum of Juvenile- and Adult-Onset Huntington Disease: A National Cohort and Enroll-HD Observational Study. Neurology. 2025. PMID: 40262071. doi:10.1212/WNL.0000000000213525
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。